B:8.75” T:8.5” How to use EpiPen® and EpiPen® Jr (epinephrine) Auto-Injectors. Remove the EpiPen® Auto-Injector from the carrier tube and follow these 2 simple steps: 1 • Hold firmly with orange tip pointing downward. • Remove blue safety cap by pulling straight up. Do not bend or twist. 2 • Swing and push orange tip firmly into mid-outer thigh until you hear a ‘click’. Built-in needle protection •W hen the EpiPen® Auto-Injector is removed, the orange needle cover automatically extends to cover the injection needle, ensuring the needle is never exposed. ! After administration, patients should seek medical attention immediately or go to the emergency room. For the next 48 hours, patients must stay within close proximity to a healthcare facility or where they can call 911. For more information visit EpiPen.ca. EpiPen® and EpiPen® Jr Auto-Injectors are indicated for the emergency treatment of anaphylactic reactions in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. They are intended for immediate self-administration for the emergency treatment of severe allergic reactions (Type I), including anaphylaxis associated with foods, stinging and biting insects, medications, latex, other allergens, and for idiopathic and exercise-induced anaphylaxis. Selection of the appropriate dosage strength is determined according to patient body weight. There are no absolute contraindications to the use of epinephrine in a life-threatening allergic situation. Epinephrine use should be avoided in patients with cardiogenic, traumatic, or hemorrhagic shock; cardiac dilation; and/or cerebral arteriosclerosis. Epinephrine use should be avoided in patients with organic brain damage and in patients with narrow-angle glaucoma. Administer with caution to elderly or hyperthyroid individuals, pregnant women, and individuals with cardiovascular disease or diabetes. Adverse reactions of epinephrine include transient, moderate anxiety; feelings of over stimulation; apprehensiveness; restlessness; tremor; weakness; shakiness; dizziness; sweating; tachycardia; palpitations; pallor; nausea and vomiting; headache; and/or respiratory difficulties. EpiPen® and EpiPen® Jr Auto-Injectors are designed as emergency supportive therapy only. They are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. © 2013 Pfizer Canada Inc., Kirkland, Quebec H9J 2M5 • Toll free: 1-877-EPIPEN1 (1-877-374-7361) • EpiPen®, EpiPen® Jr are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned affiliate, Dey Pharma, L.P. of Napa, California USA; sub-licensee, Pfizer Canada Inc., Kirkland, Quebec, H9J 2M5 D000041397 Cyan, Ogilvy Healthworld 33 yonge street, 12th floor, toronto, onTARIO M5E 1X6 Magenta, Trusted for over 25 years. Yellow, LIVE: None BUILD DATE: Jan. 29/13 CATEGORY: Direct Mail FILE: 36362-01-Eng-HCP-Instruction TRIM: 8.5” x 11” BUILD OP: JM FORMAT: Instruction Sheet AD #: None BLEED: 8.75” x 11.25” REV DATE: Feb. 13/13 PICK UP: 34430-3 REV OP: JM IMAGES: None JOB #: S.PFZ.PFZEPI.13016.B.011 LINE SCREEN: 150 TelEPHONE: (416) 363-3772 ACCOUNT: Lisa Bezzant CAMPAIGN / CREATIVE NAME: Instruction Sheet redworkstoronto.com PRODUCTION: Terri Maida ITEM DESCRIPTION: None PRINT SCALE: 100% Black 1 PASS: 2 CLIENT: Pfizer Inc. OP: NOTES: O U T P U T F R O M T RA N S F E R D I S K Myriad Pro, Myriad, Myriad MM C=0 M=65 Y=95 K=0, C=0 M=8 Y=73 K=0, C=40 M=0 Y=80 K=0, PMS 659 C, PMS 668 C, C=0 M=100 Y=91 K=0 PMS 564 C, GALLEY: pfizer_Logo_4C.ai Up to Date RXD-MEMBER-E-K.eps Up to Date KNG0901PEO-P1_V1-382-SFC.psd 1234 ppi KNG0901PEO-O1_V2-376-SFC.psd 1283 ppi, 1282 ppi KNG0901PEO-S1_V1-04-2009 77-SFC.psd 1184 ppi, 1184 ppi PAAB-K.EPS Up to Date EPIPEN-SIMPLE-E-CMYK.ai Up to Date CMYK CMYK CMYK Up to Date Up to Date Up to Date FEB. 15/13 PR: B:11.25” T:11” • H old on thigh for several seconds.
© Copyright 2019